In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy
Session

Event : ESC Congress 2016

Topic : Acute Coronary Syndromes – Pathophysiology and Mechanisms

  • Session type : EBAC Accredited Educational Programme
  • Date : 27 August 2016
  • Time : 15:30 - 17:00
  • Organised by University Hospital, Umeå / Course Director: Prof Ulf Näslund / Supported by an unrestricted educational grant from AstraZeneca

8 presentations in this session

Welcome and introduction - The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy.

Event : ESC Congress 2016

  • Session : The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy
  • Speaker : D Capodanno (Catania,IT)
  • Organised by University Hospital, Umeå / Course Director: Prof Ulf Näslund / Supported by an unrestricted educational grant from AstraZeneca

The patient journey after an acute coronary syndrome - A clinical case study.

Event : ESC Congress 2016

  • Session : The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy
  • Speaker : S James (Uppsala,SE)
  • Organised by University Hospital, Umeå / Course Director: Prof Ulf Näslund / Supported by an unrestricted educational grant from AstraZeneca

Discussion - The patient journey after an acute coronary syndrome - A clinical case study.

Event : ESC Congress 2016

  • Session : The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy
  • Speaker : D Capodanno (Catania,IT), C Hamm (Bad Nauheim,DE), S James (Uppsala,SE), P Steg (Paris,FR), M Bonaca (Boston,US)
  • Organised by University Hospital, Umeå / Course Director: Prof Ulf Näslund / Supported by an unrestricted educational grant from AstraZeneca

Optimising antiplatelet therapy from first medical contact to discharge.

Event : ESC Congress 2016

  • Session : The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy
  • Speaker : P Steg (Paris,FR)
  • Organised by University Hospital, Umeå / Course Director: Prof Ulf Näslund / Supported by an unrestricted educational grant from AstraZeneca

Discussion - Optimising antiplatelet therapy from first medical contact to discharge.

Event : ESC Congress 2016

  • Session : The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy
  • Speaker : D Capodanno (Catania,IT), C Hamm (Bad Nauheim,DE), S James (Uppsala,SE), P Steg (Paris,FR), M Bonaca (Boston,US)
  • Organised by University Hospital, Umeå / Course Director: Prof Ulf Näslund / Supported by an unrestricted educational grant from AstraZeneca

Who, when and why - The rationale to treat beyond 12 months.

Event : ESC Congress 2016

  • Session : The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy
  • Speaker : M Bonaca (Boston,US)
  • Organised by University Hospital, Umeå / Course Director: Prof Ulf Näslund / Supported by an unrestricted educational grant from AstraZeneca

Discussion - Who, when and why - The rationale to treat beyond 12 months.

Event : ESC Congress 2016

  • Session : The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy
  • Speaker : D Capodanno (Catania,IT), C Hamm (Bad Nauheim,DE), S James (Uppsala,SE), P Steg (Paris,FR), M Bonaca (Boston,US)
  • Organised by University Hospital, Umeå / Course Director: Prof Ulf Näslund / Supported by an unrestricted educational grant from AstraZeneca

Summary and close - The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy.

Event : ESC Congress 2016

  • Session : The clinical journey after an acute coronary syndrome: strategies for optimising antiplatelet therapy
  • Speaker : C Hamm (Bad Nauheim,DE)
  • Organised by University Hospital, Umeå / Course Director: Prof Ulf Näslund / Supported by an unrestricted educational grant from AstraZeneca

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are